Bright Minds Biosciences Inc. (DRUG)
Largest Insider Buys in Sector
DRUG Stock Price History Chart
DRUG Stock Performance
About Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The …
Insider Activity of Bright Minds Biosciences Inc.
Over the last 12 months, insiders at Bright Minds Biosciences Inc. have bought $7.23M and sold $0 worth of Bright Minds Biosciences Inc. stock.
On average, over the past 5 years, insiders at Bright Minds Biosciences Inc. have bought $7.23M and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Cormorant Asset Management, LP (10 percent owner) — $122.98M.
The last purchase of 184,331 shares for transaction amount of $4M was made by Cormorant Asset Management, LP (10 percent owner) on 2024‑11‑04.
List of Insider Buy and Sell Transactions, Bright Minds Biosciences Inc.
| 2024-11-04 | 10 percent owner | 184,331 1.3083% | $21.70 | $4M | -21.92% | |||
| 2024-10-16 | 10 percent owner | 50,000 0.3836% | $23.46 | $1.17M | +46.67% | |||
| 2024-10-15 | 10 percent owner | 372,591 0.6743% | $5.53 | $2.06M | +9.56% |